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This work reports on the use of two different Monte Carlo codes (GEANT4 and MCNPX) for assessing the dose reduction
using bismuth shields in computer tomography (CT) procedures in order to protect radiosensitive organs such as eye lens, thyroid
and breast. Measurements were performed using head and body PMMA phantoms and an ionisation chamber placed in five dif-
ferent positions of the phantom. Simulations were performed to estimate Computed Tomography Dose Index values using
GEANT4 and MCNPX. The relative differences between measurements and simulations were <10 %. The dose reduction
arising from the use of bismuth shielding ranges from 2 to 45 %, depending on the position of the bismuth shield. The percentage
of dose reduction was more significant for the area covered by the bismuth shielding (36 % for eye lens, 39 % for thyroid and 45 %
for breast shields).
INTRODUCTION
The use of computed tomography (CT), which started
in the early 1970s, and its dissemination in clinical prac-
tice in the following decades very positively impacted
diagnostic radiology worldwide(1, 2). The introduction
of multidetector CT (MDCT) systems provides better
image quality with improved spatial resolution but
results in higher doses to the patients(1, 2). Therefore, it
is extremely important to perform the dosimetric as-
sessment of CT examinations and develop methods to
reduce patient doses during CT scans.
According to ICRP Publication 103, the tissue
weighting factor for breast and thyroid are 0.12 and
0.04, respectively. The eye lens is also considered an
organ at risk to low-dose radiation, especially because
of cataract induction(3).
The use of bismuth-impregnated latex shields is a
method to protect the organs at risk from direct ex-
posure in CT procedures(4 – 8). Chang et al.(5) showed
the effective performance of bismuth shielding to
reduce the unnecessary radiation dose of CTexamina-
tions while preserving image quality. Hopper et al.(6)
determined a reduction of 50 % in dose to the eye lens
during a cranial CT scan.
Monte Carlo simulations can make a very important
contribution in assessing absorbed doses in organs, pro-
viding information that is not assessed from measure-
ments. In this study, state-of-the-art Monte Carlo
computer programs, MCNPX (Monte Carlo N-Particle
eXtended) and GEANT4 (GEometry ANd Tracking),
are used. The MCNPX code is a well-established
method to assess the Computed Tomography Dose
Index (CTDI) and absorbed doses in CT scans(5, 7, 9).
GEANT4 is an object-oriented software toolkit for the
simulation of the transport of particles through matter,
and it is used in avariety of application domains, includ-
ing medical physics and radiation protection. Its func-
tionality and modelling capabilities continue to be
studied(10).
The main objectives of this work are (i) to evaluate
the effectiveness of bismuth shielding on dose reduction
during CT examinations for three different types of
shields (eye lens, thyroid and breast) and (ii) to bench-
mark two MC codes—GEANT4 and MCNPX—in
the MC computation of CTDIs for the assessment of
radiation dose reduction using bismuth shielding in CT
scans.
MATERIALS AND METHODS
Dose measurements
The measurements were carried out on a GE#
Brightspeed Elite CT scanner using standard head
and body PMMA phantoms, with diameter of 16 and
32 cm, respectively, and length of 15 cm (Pro-
Projectw). Each phantom has four peripheral holes
(designated in sequence at 08, 908, 1808 and 2708) and
one central hole where a pencil ionisation chamber
(IC) (RaySafeTM) can be placed. Commercial
bismuth shields for the eye lens, thyroid and breast
(Kiran#) were utilised in this study (0.06-mm Pb
equivalence at 120 kVp).
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The measurements were performed five times for
each hole with and without bismuth shielding in
order to calculate the dose reduction due to the use of
shields. The eye and thyroid shields were used for the
head phantom and the breast shield for the body
phantom. Each phantom was positioned aligning the
centre of the phantom with the rotation axis of the
gantry (Figure 1). The CT examination was made
at 120 kVp, 200 mAs (head), 300 mAs (body) and
10 mm of collimation for a complete rotation of 1 s
(one slice).
Computational CT model
Two MC codes were used for the purpose of this
work—GEANT4 and MCNPX. The GEANT4, an
object-oriented Cþþ computer language program,
provides comprehensive detector and physics mod-
elling capabilities inserted in a flexible structure(10).
MCNPX is a state-of-the-art computer code for
particle transport simulation, with the capability of
tracking 34 particle types at nearly all energies,
and simulation of different geometries using input
cards.
The focal spot of the system is located 54 cm from
the centre of the CT gantry. The program SRS-78
(IPEM)(11) was used to simulate a typical X-ray energy
spectrum of 120 kVp. The scanner comprises an X-ray
beam filtration that includes both head and body
bowtie filters and a collimator. The collimator forces
the fan beam to be 558 in the x–y plane and 10-mm
collimation in the z plane. In the absence of detailed in-
formation, the shape and dimensions of a typical
bowtie were initially implemented in the CT model and
its geometry/shape was adjusted by a trial and error it-
erative method until the relative differences between the
measurement and the simulations were ,10 %. The
CT scanner model simulated in GEANT4 is shown in
Figure 2.
In the MCNPX code, the tally F6:p results are
normalised per source particle. In order to convert the
units from MCNPX results (MeV/g/particle) into
units of absorbed dose (mGy), a conversion factor is
required. The CF used in this study has been described
in a previous paper by Gu et al.(12) as a function of
beam energy E and collimation NT. The CF is defined
in Equation 1, where CTDI(100, air, measured)E,NT (mGy)
is taken in air by the IC at the scanner isocentre, and
CTDI(100, air, simulated per particle)E,NT (Mev g
21 per par-
ticle) is obtained by simulating the IC placed on the
phantom under the same conditions.
ðCFÞE;NT¼
ðCTDI100; air; measured ÞE; NT
ðCTDI100; air; simulated per particleÞE;NT
:
ð1Þ
Then, the absolute value for the simulated dose
(mGy) is obtained multiplying the simulated dose in
MeV g21 per particle by the CF value, as described in
the following equation:
Dabsolute ¼ Dsimulated  CF: ð2Þ
GEANT4 can calculate directly the mean absorbed
dose per particle. Nevertheless, in order to know the
total absorbed dose in the sensitive volume of the
ionisation chamber, the results have to be normal-
ised by the same method described earlier. The
geometry and material composition of the bismuth
shields were also implemented in GEANT4 and
MCNPX.
RESULTS AND DISCUSSION
Validation of the CT scanner model
Two sets of measurements were performed in order to
validate the CT scanner model implemented in
Figure 1. Experimental set-up with the ionisation chamber
placed in the central hole of the head phantom with an eye
lens bismuth shield.
Figure 2. CT scanner set-up developed with GEANT4, and
simulated geometries of bismuth shields, (a) eye lens shield,
(b) thyroid shield and (c) breast shield.
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GEANT4 and MCPNX, including the ionisation
chamber, the CTDI phantoms and free-in-air mea-
surements. In the first set, a single axial free-in-air
measurement using an IC was made, in order to
obtain the conversion factor (CF). The second set of
measurements used to validate the CT model com-
prises the CTDI phantom and the IC placed in the
centre and in the four peripheral insert positions of
the phantom. The measurements were performed for
both the head and body phantoms, as well as for the
two bowtie filters available (head and body).
The CTDI100 values for measurements and for
Monte Carlo simulation obtained with MCNPX and
GEANT4 are displayed in Table 1 (for 200 mAs) and
Table 2 (for 300 mAs) for the head and body
phantom without bismuth, respectively. The results
of Table 1 show good agreement between simulations
and measurements, with a maximum percentage
difference of 8 % between GEANT4 and measure-
ments. The measured CTDI100 for the 08 position (the
position representing superficial organs) of the head
phantom was 36.4 mGy for measurements, 34.6 mGy
for MCNPX and 34.4 mGy for GEANT4.
Regarding the measurements with the body
phantom (Table 2), the value obtained for the 08 pos-
ition was 32.9 mGy. With MCNPX and GEANT4,
the values for position 08 were 32.6 and 33.0 mGy, re-
spectively. The two MC codes show a maximum per-
centage difference of 6 %
For the measurements without bismuth shielding,
the highest dose value was obtained for the position
08 of the head phantom. The lowest value corre-
sponds to the 1808 position, because the radiation
attenuation induced by CT table. For the simulation
studies, this was not verified, and the highest dose
value in the centre was slightly .08 (Figure 3).
Dose measurements with bismuth shielding
Tables 3 and 4 show the measured and simulated
CTDI100 values in the head phantom with eye lens
and thyroid bismuth shielding, respectively. The rela-
tive differences between measurements and simula-
tions are ,10 %. The main complication in setting up
an MC simulation arises from the need to validate
and define the geometry and the experimental set-up
with high accuracy. Consequently, the relative differ-
ences obtained are mainly due to uncertainties of
X-ray spectra (15 %)(11), filtration, properties of
materials and geometry.
Using the eye lens bismuth shielding, the obtained
CTDI values for the 08 position are 23.2 mGy (mea-
surements), 21.9 mGy (MCNPX) and 21.9 mGy
(GEANT4). Using the thyroid bismuth shield, the
obtained values are 22.0 mGy (measurements), 21.4
mGy (MCNPX) and 21.1 mGy (GEANT4). The last
column of the tables indicates a relative difference
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between the two MC programs up to 5 %, except for
the central hole with the eye lens bismuth shield (rela-
tive difference of 7 %).
Table 5 presents the CTDI100 values for measure-
ments and simulations with GEANT4 and MCNPX,
in the body phantom with breast shielding. The
CTDI100 values for the 08 position with the breast
shield were 17.9, 16.7 and 17.3 mGy for measurements,
MCNPX and GEANT4 simulations, respectively.
Figures 4–6 show the percentage of dose reduction
using the three different types of bismuth shields. In
all cases, the major dose reduction is for the ionisation
chamber inserted in the 08 position, which was
expected since this corresponds to the position adja-
cent to the bismuth shielding. For measurements, the
dose reduction at the 08 position was 36, 39 and 45 %
for eye lens, thyroid and breast bismuth shields, re-
spectively. The dose reduction at the centre was ap-
proximately half of those at 08, and one-third at the
lateral positions (908 and 2708). These results indicate
the effect of the area covered by the shields on the
absorbed dose.
In general, there is a good agreement between the
measurements and the Monte Carlo simulations for the
three cases. Previous studies have demonstrated similar
results and conclusions supporting the efficacy of
bismuth shields on dose reductions. In fact, McLaughlin
et al.(13) recommend the use of thyroid shields in routine
practice. Catuzzo et al.(8) demonstrate that the use of a
bismuth shield reduces significantly both organ and ef-
fective radiation dose with a consequent reduction in the
risk for the patient. A good agreement, ,5 %, between
the GEANT4 and MCNPX Monte Carlo simulation
results, is also observed.
Additional work is necessary to corroborate these
results and give more detailed information about the
dose reduction in the organs of interest. Some authors
have demonstrated that other techniques, such as
automatic tube modulation and automatic exposure
control, show good results in dose reduction without
degradation of image quality and could offer a better
option than bismuth(14, 15).
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Figure 3. CT scan images of the PMMA head phantom for
120 kVp and 200 mAs, (a) without bismuth shield and (b)
with an eye lens bismuth shield.
M.MENDES ETAL.
Page 4 of 7
Table 3. Comparison between measured CTDI100 and simulated CTDI100 with MCNPX and GEANT4, from a single scan for the CTDI head phantom with eye lens bismuth
shielding.
Measured [DMEA]
(mGy)
MCNPX [DMCNPX]
(mGy)
(DMCNPX 2 DMEA)/
DMEA (%)
GEANT4 [DGEANT4]
(mGy)
(DGEANT4 2 DMEA)/
DMEA (%)
(DGEANT4 2 DMCNPX)/
DMCNPX (%)
08 23.2+1.17 21.9+0.48 25.52 21.9+1.21 25.84 20.12
908 30.1+1.52 30.9+0.55 2.44 30.1+1.12 20.31 22.69
1808 28.8+1.45 29.1+0.55 0.94 27.6+0.24 24.07 24.96
2708 30.5+1.54 30.9+0.56 1.23 29.4+0.68 23.71 24.88
Centre 27.9+1.42 30.4+0.37 9.02 28.1+1.04 0.77 27.57
CTDIw 28.1+0.67 28.9+0.22 3.06 27.5+0.46 21.92 24.84
Table 4. Comparison between measured CTDI100 and simulated CTDI100 with MCNPX and GEANT4, from a single scan for the CTDI head phantom with thyroid bismuth
shielding.
Measured [DMEA]
(mGy)
MCNPX [DMCNPX]
(mGy)
(DMCNPX 2 DMEA)/
DMEA (%)
GEANT4 [DGEANT4]
(mGy)
(DGEANT4 2 DMEA)/
DMEA (%)
(DGEANT4 2 DMCNPX)/
DMCNPX (%)
08 22.0+1.11 21.4+0.46 22.67 21.1+0.91 24.09 21.46
908 32.4+1.63 30.7+0.55 25.20 30.4+0.14 26.20 21.06
1808 29.6+1.49 29.0+0.53 22.12 27.7+0.12 26.55 24.53
2708 32.1+1.61 30.7+0.55 24.34 29.4+0.37 28.57 24.42
Centre 27.2+1.36 29.9+0.37 10.15 28.8+0.47 5.98 23.79
CTDIw 28.4+0.67 28.6+0.21 0.70 27.7+0.23 22.57 23.25
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CONCLUSIONS
In this study, the effectiveness of bismuth shielding on
dose reduction for radiosensitive organs during CT
examinations was assessed for three different types of
shields (eye lens, thyroid and breast). The highest dose
reduction was obtained for breast bismuth shields.
The results are useful to understand the effect of such
shields on primary radiation to the patients exposed
in CT scans. However, additional work is necessary in
order to understand the effect on image quality and
to assess the effective absorbed dose in organs. A
good agreement was achieved between the two Monte
Carlo computer programs used, with relative differ-
ences between them being ,5 %, as well as betweenTa
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Figure 4. Comparison between measurements and GEANT4
and MCNPX simulations for dose reductions achieved using
an eye lens bismuth shielding (120 kVp, 200 mAs).
Figure 5. Comparison between measurements and GEANT4
and MCNPX simulations for dose reductions achieved using
thyroid bismuth shielding (120 kVp, 200 mAs).
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the measured and the simulated doses. Therefore, the
validated computational models can be used, in the
future, to perform the dosimetric assessment of more
complex scenarios including the implementation of
human voxel phantoms, tube current modulation and
other dose reduction techniques.
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